| (AUD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 15.67M | 29.60% |
| Operating expense | — | — |
| Net income | -14.94M | -25.07% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MAP.AX returned -42.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -27.6% |
| 1 year | -42.7% |
| All-time high | $0.40 (Jan 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MAP.AX would be worth today ›No. Microba Life Sciences Limited has not paid a dividend in the past 12 months.
Microba Life Sciences Limited is part of the Healthcare sector.
Microba Life Sciences Limited has a market cap of 39.44M AUD, based on the latest quote.
